Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Accured Expenses (2017 - 2025)

CorMedix has reported Change in Accured Expenses over the past 13 years, most recently at $52.3 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $52.3 million for Q4 2025, up 248.94% from a year ago — trailing twelve months through Dec 2025 was $100.8 million (up 338.42% YoY), and the annual figure for FY2025 was $100.8 million, up 338.42%.
  • Change in Accured Expenses reached $52.3 million in Q4 2025 per CRMD's latest filing, down from $54.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $54.7 million in Q3 2025 and bottomed at -$6.6 million in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was $819670.5 (2022), compared with a mean of $6.4 million.
  • The largest annual shift saw Change in Accured Expenses tumbled 4758.3% in 2021 before it soared 1078.62% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $1.1 million in 2021, then dropped by 26.81% to $807375.0 in 2022, then surged by 126.72% to $1.8 million in 2023, then soared by 718.48% to $15.0 million in 2024, then surged by 248.94% to $52.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CRMD at $52.3 million in Q4 2025, $54.7 million in Q3 2025, and -$6.6 million in Q2 2025.